Cargando…
MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes
Recurrent mutations in the myogenic transcription factor MYOD1 and PIK3CA were initially described in a subset of embryonal rhabdomyosarcomas. Recently, two independent studies demonstrated presence of MYODI (L122R) mutations as the basis to re-classify a spindle cell rhabdomyosarcoma, along with a...
Autores principales: | Rekhi, Bharat, Upadhyay, Pawan, Ramteke, Manoj P, Dutt, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133269/ https://www.ncbi.nlm.nih.gov/pubmed/27562493 http://dx.doi.org/10.1038/modpathol.2016.144 |
Ejemplares similares
-
Biological Role and Clinical Implications of MYOD1(L122R) Mutation in Rhabdomyosarcoma
por: Di Carlo, Daniela, et al.
Publicado: (2023) -
Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation
por: Choo, Florence, et al.
Publicado: (2022) -
Disruption of the MyoD/p21 Pathway
in Rhabdomyosarcoma
por: Weintraub, Michael, et al.
Publicado: (1997) -
Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile
por: Schleicher, Sabine, et al.
Publicado: (2020) -
Oral spindle cell/sclerosing rhabdomyosarcoma on mandible with anaplastic lymphoma kinase expression mimicking inflammatory myofibroblastic tumor
por: Lee, Joo Young, et al.
Publicado: (2023)